Smith A D, Smith D L, Zigmond M J, Amalric M, Koob G F
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA.
Psychopharmacology (Berl). 2000 Mar;148(4):355-60. doi: 10.1007/s002130050063.
Pharmacological manipulation of the dopaminergic system with antipsychotic agents disrupts motor behavior. Although most antipsychotic drugs have high affinity for D2 receptors, they also interact with other dopamine receptor subtypes. Therefore, the role of each of these receptor subtypes on motor performance is unclear.
The present study sought to investigate the relative importance of D1, D2, and D3 receptors on performance in a conditioned reaction-time task known to be extremely sensitive to dysfunction of the dopaminergic nigrostriatal pathway.
Rats were trained to release a lever in response to a visual cue within a reaction-time limit to receive a reinforcer (45mg food pellet). After the behavior of the rats had stabilized, the effects of a D1 (A69024), D2 (eticlopride), and D3 (nafadotride) receptor antagonists were assessed.
A-69024 had no effect on performance at any dose tested (0.3, 0.6, and 1.3 mg/kg s.c.). Nafadotride (0.1, 0.3, and 1 mg/kg s.c.) produced only a mild deficit in performance at the highest dose. This deficit was characterized by an increase in the number of delayed responses with a non-significant decrease in the number of premature responses indicative of non-specific sedative effects. In contrast, the D2 receptor antagonist eticlopride (0.005, 0.01, and 0.02 mg/kg s.c.) produced profound deficits in performance as evidenced by a dose-dependent decrease in the number of correct responses. This decrease was accompanied by an increase in the number of delayed responses and a lengthening of the reaction time at the highest doses.
These results provide further evidence that the execution of the reaction-time task is dependent preferentially upon the activation of D2 receptors, but not D1 or D3 receptors.
使用抗精神病药物对多巴胺能系统进行药理学调控会扰乱运动行为。尽管大多数抗精神病药物对D2受体具有高亲和力,但它们也会与其他多巴胺受体亚型相互作用。因此,这些受体亚型各自在运动表现中的作用尚不清楚。
本研究旨在探讨D1、D2和D3受体在一种已知对多巴胺能黑质纹状体通路功能障碍极为敏感的条件反应时间任务中的相对重要性。
训练大鼠在反应时间限制内对视觉提示做出反应以释放杠杆,从而获得强化物(45毫克食物颗粒)。在大鼠行为稳定后,评估D1(A69024)、D2(依替必利)和D3(萘法朵利)受体拮抗剂的作用。
A-69024在任何测试剂量(0.3、0.6和1.3毫克/千克皮下注射)下对表现均无影响。萘法朵利(0.1、0.3和1毫克/千克皮下注射)仅在最高剂量时产生轻微的表现缺陷。这种缺陷的特征是延迟反应数量增加,同时过早反应数量无显著减少,提示存在非特异性镇静作用。相比之下,D2受体拮抗剂依替必利(0.005、0.01和0.02毫克/千克皮下注射)导致明显的表现缺陷,表现为正确反应数量呈剂量依赖性减少。这种减少伴随着延迟反应数量增加以及最高剂量时反应时间延长。
这些结果提供了进一步的证据,表明反应时间任务的执行优先依赖于D2受体的激活,而非D1或D3受体。